When cancer cells undergo necrotic apoptosis induced by various treatments, neutrophils and macrophages in the tumor microenvironment are stimulated to produce immune suppression through the release of interleukin-1α (IL-1α), which partially explains the limited effectiveness of combined radiotherapy, chemotherapy, and immunotherapy [46]. Here, IL1A is linked to neoplasm.